TY - JOUR
T1 - Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota
T2 - a double-blinded randomized placebo trial
AU - Lai, Hao
AU - Li, Yunfeng
AU - He, Yafang
AU - Chen, Fangyao
AU - Mi, Baibing
AU - Li, Junqi
AU - Xie, Jiawen
AU - Ma, Guoqing
AU - Yang, Jinzhao
AU - Xu, Kun
AU - Liao, Xia
AU - Yin, Yan
AU - Liang, Junrong
AU - Kong, Liyun
AU - Wang, Xinyan
AU - Li, Zhongxia
AU - Shen, Yuan
AU - Dang, Shaonong
AU - Zhang, Lei
AU - Wu, Qian
AU - Zeng, Lingxia
AU - Shi, Lin
AU - Zhang, Xuguang
AU - Tian, Tian
AU - Liu, Xin
N1 - Funding Information:
This study was supported by Xi’an Jiaotong University (xjj2018146, DW080038K0000004), BYHEALTH Nutrition and Health Research Foundation (TY0191118), National Natural Science Foundation of China (82173504, 82011530197), and National Key R&D Program of China (2017YFC0907200, 2017YFC0907201). We thank all the participants, on-site field workers, investigators in Xi’an Jiaotong University and Xi’an Daxing Hospital, and all the members in Xin Liu Laboratory in assisting the intervention procedure, and discussion of the manuscript.
Publisher Copyright:
© 2023 The Author(s). Published with license by Taylor & Francis Group, LLC.
PY - 2023
Y1 - 2023
N2 - Dietary fibers/probiotics may relieve constipation via optimizing gut microbiome, yet with limited trial-based evidences. We aimed to evaluate the effects of formulas with dietary fibers or probiotics on functional constipation symptoms, and to identify modulations of gut microbiota of relevance. We conducted a 4-week double-blinded randomized placebo-controlled trial in 250 adults with functional constipation. Intervention: A: polydextrose; B: psyllium husk; C: wheat bran + psyllium husk; D: Bifidobacterium animalis subsp. lactis HN019 + Lacticaseibacillus rhamnosus HN001; Placebo: maltodextrin. Oligosaccharides were also included in group A to D. 16S rRNA sequencing was used to assess the gut microbiota at weeks 0, 2, and 4. A total of 242 participants completed the study. No time-by-group effect was observed for bowel movement frequency (BMF), Bristol stool scale score (BSS), and degree of defecation straining (DDS), while BSS showed mean increases of 0.95–1.05 in group A to D (all P < 0.05), but not significantly changed in placebo (P = 0.170), and 4-week change of BSS showed similarly superior effects of the interventions as compared placebo. Group D showed a marginal reduction in plasma 5-hydroxytryptamine. Group A resulted in a higher Bifidobacterium abundance than placebo at week 2 and 4. Fourteen genera showed intervention-specific increasing or decreasing trends continuously, among which Anaerostipes showed increasing trends in groups B and C, associated with BMF increase. Random forest models identified specific baseline microbial genera panels predicting intervention responders. In conclusion, we found that the dietary fibers or probiotics may relieve hard stool, with intervention-specific changes in gut microbiota relevant to constipation relief. Baseline gut microbiota may predispose the intervention responsiveness. ClincialTrials.gov number, NCT04667884.
AB - Dietary fibers/probiotics may relieve constipation via optimizing gut microbiome, yet with limited trial-based evidences. We aimed to evaluate the effects of formulas with dietary fibers or probiotics on functional constipation symptoms, and to identify modulations of gut microbiota of relevance. We conducted a 4-week double-blinded randomized placebo-controlled trial in 250 adults with functional constipation. Intervention: A: polydextrose; B: psyllium husk; C: wheat bran + psyllium husk; D: Bifidobacterium animalis subsp. lactis HN019 + Lacticaseibacillus rhamnosus HN001; Placebo: maltodextrin. Oligosaccharides were also included in group A to D. 16S rRNA sequencing was used to assess the gut microbiota at weeks 0, 2, and 4. A total of 242 participants completed the study. No time-by-group effect was observed for bowel movement frequency (BMF), Bristol stool scale score (BSS), and degree of defecation straining (DDS), while BSS showed mean increases of 0.95–1.05 in group A to D (all P < 0.05), but not significantly changed in placebo (P = 0.170), and 4-week change of BSS showed similarly superior effects of the interventions as compared placebo. Group D showed a marginal reduction in plasma 5-hydroxytryptamine. Group A resulted in a higher Bifidobacterium abundance than placebo at week 2 and 4. Fourteen genera showed intervention-specific increasing or decreasing trends continuously, among which Anaerostipes showed increasing trends in groups B and C, associated with BMF increase. Random forest models identified specific baseline microbial genera panels predicting intervention responders. In conclusion, we found that the dietary fibers or probiotics may relieve hard stool, with intervention-specific changes in gut microbiota relevant to constipation relief. Baseline gut microbiota may predispose the intervention responsiveness. ClincialTrials.gov number, NCT04667884.
KW - Dietary fiber
KW - functional constipation
KW - gut microbiota
KW - nutritional intervention
KW - probiotics
UR - https://www.scopus.com/pages/publications/85152979953
U2 - 10.1080/19490976.2023.2197837
DO - 10.1080/19490976.2023.2197837
M3 - Article
C2 - 37078654
AN - SCOPUS:85152979953
SN - 1949-0976
VL - 15
JO - Gut Microbes
JF - Gut Microbes
IS - 1
M1 - 2197837
ER -